Financial Burden in Families of Children with West Syndrome

Area of Science:

• Pediatric Neurology
• Health Economics
• Clinical Pediatrics

Background:

• West syndrome (WS) is a rare and severe form of epilepsy in infants and young children.
• The economic impact of chronic childhood illnesses, particularly neurological disorders, is a growing concern for families and healthcare systems.
• Understanding the financial burden associated with WS is crucial for developing targeted support strategies.

Purpose of the Study:

• To quantify the illness-related expenditure incurred by families during the first year of a child's West syndrome diagnosis.
• To identify key factors that determine the financial strain experienced by these families.
• To assess the overall economic impact of West syndrome on affected households.

Main Methods:

• A cross-sectional study involving 85 children diagnosed with West syndrome within one year of symptom onset.
• Data collection included parental interviews and case record reviews to capture direct medical and nonmedical costs over the first year.
• Statistical analysis explored determinants of financial burden, including parental education and treatment choices.

Main Results:

• The median annual treatment cost for West syndrome was substantial, reaching INR 27,035.
• Direct medical expenses (INR 18,802) and nonmedical expenses (INR 6,550) significantly contributed to the total financial drain.
• Parental education level and the selection of first-line treatment emerged as significant predictors of healthcare expenditure.

Conclusions:

• West syndrome imposes a considerable financial burden on families, necessitating robust support mechanisms.
• The study underscores the indirect economic impact on the broader healthcare system due to the management of this condition.
• Further research into cost-effective management and financial aid for WS families is warranted.